Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
29%(2 trials)

Phase Distribution

Ph not_applicable
9
90%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
1(10.0%)
N/ANon-phased studies
9(90.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(7)
Terminated(1)
Other(2)

Detailed Status

Completed7
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (10.0%)
N/A9 (90.0%)

Trials by Status

withdrawn110%
completed770%
unknown220%

Recent Activity

0 active trials
Showing 5 of 10
completednot_applicable

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

NCT05199714
unknownnot_applicable

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

NCT04243629
completednot_applicable

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

NCT02985866
completednot_applicable

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

NCT04163874
completedphase_3

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

NCT03979352
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT05199714Not Applicable

A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 Diabetes

Completed
NCT04243629Not Applicable

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Unknown
NCT02985866Not Applicable

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1

Completed
NCT04163874Not Applicable

Alleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Completed
NCT03979352Phase 3

Effect of SGLT2i in Conjunction With the Artificial Pancreas on Improving the Glycemia in T1DM in the Outpatient Setting

Completed
NCT04189510Not Applicable

Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation

Withdrawn
NCT02620878Not Applicable

Artificial Pancreas in Pediatric Patients (PEDarPAN)

Completed
NCT03581968Not Applicable

Efficacy of Closed-Loop Strategy With and Without a Learning Component in Children and Adolescents With Type 1 Diabetes at a Diabetes Camp

Completed
NCT02844517Not Applicable

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Completed
NCT00735228Not Applicable

Tight Glycemic Control by Artificial Pancreas

Unknown

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10